OTC Flashcards

1
Q

Medications to avoid in OTC

A

valproate, haldol, steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Amonnia levels in acute encephalopathy

A

> 200, often 500-1,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does OTC do in urea cycle

A

catalizes the reaction of carbamoyl phosphate and ornithine to form citruline in mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how is citruline involved in normal urea cycle

A

-converted to arginosuccinate, then arginine in hepatocyte cytoplasm
-eventually converted to urea and excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does excess carbamoyl phosphate become when it is not converted by otc?

A

-orotic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factors that can precipitate crisis

A

-infection
-high protein diet (atkins)
-prolonged physical activity
-post partum
-chemo
-starvation
-meds: depakote, haldol, steroids
-surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Supportive labs of OTC during crisis

A

-elevated ammonia (often 500-1000)
-elevated glutamine (>800)
-low citruline (single digits)
-high random urine orotic acid (>20)
-respiratory alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

OTC gene therapy study name

A

Enhance
DTX301
Phase 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ages of enhance study

A

> 12 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Number of pts in enhance study

A

50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Follow up duration of pts in enhance

A

5 years of follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary endpoint of Enhance

A

to evaluate the efficacy of DTX301 on the improvement of otc function by improving ammonia levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Secondary endpoints of enhance

A

-to evaluate the effect of DTX301 on 3 response categories
-to evaluate the effect of DTX301 on hyperammonemia indicator questionnaire
-to evaluate the effect of DTX301 on executive and verbal function
-to evaluate the effect of DTX301 on occurrence of HACs
-to evaluate the effect of DTX301 on plasma ammonia over time
-evaluate safety of DTX301
-evaluate for anti-otc antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Enhance study design

A

-Cohort 1: gene therapy (n=25)
-Cohort 2: placebo (n=25)
-At week 64, groups switch treatments
-Long term follow up is at least 5 yrs, depending on which group pt was in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Enhance inclusion criteria

A

-male or female >12 yrs
-confirmed diagnosis of late onset OCT deficiency
-history of at least 1 episode of symptomatic elevated ammonia >100
-not actively hyperammonemia, not required acute treatment for an episode within last 4 weeks
-ammonia <200 at initial check
-plasma 24hr ammonia <4800 um/*h/L
-stable doses of nitrogen scavengers for at least 4 weeks
-stable protein restricted diet (daily protein intake does not vary >20% for at least 4 weeks)
-females must use contraception through wk 128

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Enhance exclusion criteria

A

-ammonia >200
-liver disease (active hepatitis or severe cirrhosis)
-liver transplant
-active infection, HIV, chronic steroids
-AAV antibodies
-marked neuro deficit
-meds like depakote
-pregnant or breastfeeding
-current

17
Q

How does sodium phenylbutyrate work

A

binds glutamine in mitochondria for excretion

18
Q

How does sodium benzoate work

A

binds glycine in mitochondria for excretion

19
Q

Which AAV is used in DTX301

A

AAV8